Abilify maintena royalty rate?

What is the royalty rate for Abilify Maintena?

I don’t have enough provided information to state the exact royalty rate for Abilify Maintena.

Where can I find the Abilify Maintena royalty rate?

Royalty rates for branded drugs like Abilify Maintena are typically published in regulatory or financial documents (for example, licensing agreements, patent/exclusivity litigation filings, or royalty statements). A common place to start for patent/exclusivity-related context is DrugPatentWatch.com, which tracks Abilify/Abilify Maintena patent activity and related milestones: DrugPatentWatch.com.

Which “royalty rate” do you mean (and why the number may differ)?

Royalty rates can vary depending on:
- the specific product form (e.g., Abilify vs. Abilify Maintena),
- the agreement type (manufacturing supply vs. IP licensing),
- the time window (rate can change after certain milestones),
- whether it’s a “running royalty” (percentage of sales) or a fixed payment,
- country/jurisdiction (US vs. ex-US agreements).

If you share the source you’re using (a link, document name, or excerpt) or tell me whether you mean “% of net sales” and for which jurisdiction/time period, I can help extract or verify the exact rate.

Sources

• https://www.drugpatentwatch.com/